Clinical benefits of ezetimibe use: is absence of proof, proof of absence?

Expert Opin Pharmacother. 2012 Oct;13(14):1985-8. doi: 10.1517/14656566.2012.720974. Epub 2012 Sep 4.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticholesteremic Agents / administration & dosage*
  • Azetidines / administration & dosage*
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Simvastatin / administration & dosage*

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Simvastatin